D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZ
3901
Ryerson Holding Corp
RYZ
$1.6B
| $219K | ﹤0.01% |
10,153
-7,501
| -42% | -$162K |
|
3902
NiSource
NI
$22.4B
| $218K | ﹤0.01% |
5,413
-3,700
| -41% | -$145K |
|
3903
Dimensional International Value ETF
DFIV
$20.7B
| $218K | ﹤0.01% |
5,096
| – | – |
|
3904
Dole
DOLE
$1.35B
| $218K | ﹤0.01% |
15,588
-37,594
| -71% | -$532K |
|
3905
Schwab Fundamental US Large Company Index ETF
FNDX
$26.4B
| $217K | ﹤0.01% |
+8,847
| New | +$206K |
|
3906
PUT
Braze
BRZE
$2.45B
| $216K | ﹤0.01% |
7,700
-200
| -3% | -$6.32K |
|
3907
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.1B
| $216K | ﹤0.01% |
4,033
-1,065
| -21% | -$53.5K |
|
|
SPNS
3908
DELISTED
Sapiens International
SPNS
| $215K | ﹤0.01% |
+7,366
| New | +$205K |
|
3909
Weibo
WB
$1.9B
| $215K | ﹤0.01% |
22,594
+11,697
| +107% | +$103K |
|
3910
Oil-Dri
ODC
$1.43B
| $215K | ﹤0.01% |
+3,643
| New | +$177K |
|
3911
CALL
Generac Holdings
GNRC
$11.9B
| $215K | ﹤0.01% |
1,500
-1,000
| -40% | -$122K |
|
3912
Asbury Automotive
ABG
$4.19B
| $215K | ﹤0.01% |
900
-66,981
| -99% | -$15.3M |
|
3913
iShares Core US REIT ETF
USRT
$4.74B
| $214K | ﹤0.01% |
3,792
-766
| -17% | -$42.9K |
|
3914
BlackRock Capital Allocation Term Trust
BCAT
$1.6B
| $214K | ﹤0.01% |
14,146
| – | – |
|
3915
Aquestive Therapeutics
AQST
$462M
| $214K | ﹤0.01% |
64,676
-114,359
| -64% | -$328K |
|
3916
Utz Brands
UTZ
$1.25B
| $211K | ﹤0.01% |
16,847
-144,531
| -90% | -$1.89M |
|
3917
Tower Semiconductor
TSEM
$26.4B
| $211K | ﹤0.01% |
+4,873
| New | +$187K |
|
3918
Ranpak Holdings
PACK
$553M
| $210K | ﹤0.01% |
58,905
-72,363
| -55% | -$268K |
|
|
SHOE
3919
PUT
Shoe Station Group
SHOE
$395M
| $210K | ﹤0.01% |
+11,200
| New | +$213K |
|
3920
ACNB Corp
ACNB
$634M
| $209K | ﹤0.01% |
4,873
-2,116
| -30% | -$88.1K |
|
3921
PUT
Beazer Homes USA
BZH
$907M
| $208K | ﹤0.01% |
+9,300
| New | +$193K |
|
3922
PUT
RXO
RXO
$4.23B
| $208K | ﹤0.01% |
+13,200
| New | +$200K |
|
|
CNTA
3923
DELISTED
Centessa Pharmaceuticals
CNTA
| $207K | ﹤0.01% |
+15,764
| New | +$200K |
|
3924
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.85B
| $207K | ﹤0.01% |
3,489
-5,615
| -62% | -$314K |
|
3925
State Street SPDR S&P China ETF
GXC
$445M
| $206K | ﹤0.01% |
2,349
-124
| -5% | -$10.4K |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.